Vol 5 (January 31, 2024): Translational Breast Cancer Research

Case Report 
A case report of low-dose apatinib in the treatment of advanced triple-negative breast cancer
Ye Lv, Huiqiang Zhang, Yanjiao Zhao, Haixia Zhang, Tao Wang
Translational Breast Cancer Research  
2024;
5:
8  
Case Report 
Poland syndrome combined with breast cancer: a case report
Shiqi Guo, Yuhui Chen, Qingyang Li, Yujiao Xie, Xiaopeng Hao, Jiandong Wang
Translational Breast Cancer Research  
2024;
5:
7  
Brief Report 
Can Hounsfield units on chest CT characterize breast nodules as cystic or solid?
Kathleen Capaccione, Elise Desperito, Arnold Caleb Asiimwe, Mary Salvatore
Translational Breast Cancer Research  
2024;
5:
6  
Editorial Commentary 
Tislelizumab: an effective treatment option for early-stage triple-negative breast cancer
Zhigang Yu
Translational Breast Cancer Research  
2024;
5:
5  
Review Article 
Implications of tumor-infiltrating lymphocytes in early-stage triple-negative breast cancer: clinical oncologist perspectives
Mahira Lopes Rosa, Tomas Reinert, Maiane Maria Pauletto, Guilherme Sartori, Marcia Graudenz, Carlos Henrique Barrios
Translational Breast Cancer Research  
2024;
5:
4  
Review Article 
Challenges in HER2-low breast cancer identification, detection, and treatment
Qian Wu, Ling Xu
Translational Breast Cancer Research  
2024;
5:
3  
Review Article 
TORCHLIGHT trial, brightening the life of more patients with advanced triple-negative breast cancer
Huiqiang Zhang, Xiao Jin, Li Bian
Translational Breast Cancer Research  
2024;
5:
1